Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-02-27 @ 10:01 AM
Study NCT ID:
NCT02173457
Status:
COMPLETED
Last Update Posted:
2019-10-25
First Post:
2014-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
Sponsor:
Chipscreen Biosciences, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CGZ302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None